N/A
Completed N=76
A Comparison Between Cognitive, Behavioral, and Cognitive-Behavioral Therapy for Generalized Anxiety Disorder
Source: ClinicalTrials.gov NCT00635999 ↗Enrolled (actual)
76
Serious AEs
0.0%
Results posted
Jan 2018
Primary outcomePrimary: High End State Function — 56.52; 43.48; 56.52; 47.62 % people meeting high endstate status
Summary
This study will evaluate the effectiveness of three adaptive coping treatments in lessening anxiety in adults with generalized anxiety disorder.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY High End State Function |
56.52; 43.48; 56.52; 47.62; 68.18; 56.52 | — |
| SECONDARY Within-group Change Represented as Cohen's d Effect Sizes |
2.38; 2.95; 2.8; 2.35; 2.81; 2.86 | — |
Eligibility Criteria
Inclusion Criteria
- Primary diagnosis of GAD
Exclusion Criteria
- Diagnosis of any of the following: panic disorder, subclinical GAD, severe depression, psychosis, or organic brain syndrome
- Currently receiving therapy for GAD or has previously received CBT
- Medical contributions to anxiety
- Currently taking antidepressant medication
- Current substance abuse
Data sourced from ClinicalTrials.gov (NCT00635999). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.